Desk›Healthcare› Goldline Pharmaceutical Ltd
Goldline Pharmaceutical Ltd
BSE 544759 · NSE GLPL · ISIN INE1CLW01015 · Group M · Active
Healthcare › Healthcare › Pharmaceuticals & Biotechnology › Pharmaceuticals
₹40.97
+2.07%
BSE close, 28 August 2026
₹39.33 cr
1.0 cr shares · Micro cap
₹8.06 cr
as published
14.2× · —
EPS ₹2.88 · BV —
—
no annual figures
12
0 selected · 0%
Reg 30
Sch. III Part A
Price 52-week, BSE
| Against 52-week high | -31.7% |
|---|---|
| Against 52-week low | +24.2% |
| Day change | +2.07% |
| Size band | Micro cap |
| Index membership | None |
Valuation as published by BSE
| Earnings per share | ₹2.88 |
|---|---|
| Price / earnings | 14.23× |
| Price / book | — |
| Book value — derived, price ÷ P/B | — |
| Return on equity | — |
| Operating margin | — |
| Net margin | — |
Results ₹ crore, as filed
RevenueNet profit one scale across all three periods, ₹ crore
| Period | Revenue ₹cr | Net profit ₹cr | EPS ₹ | OPM | NPM |
|---|---|---|---|---|---|
| Mar-26 · Q | 17.31 | 2.76 | 3.43 | 24.88% | 15.95% |
| Period3 · Q | 31.20 | 4.12 | 5.97 | 22.25% | 13.20% |
Quarter on quarter
- Revenue, quarter on quarter
- -44.5%
- Net profit, quarter on quarter
- -33.0%
- Operating margin, quarter on quarter
- +263 bps
Disclosure profile 12 filings in the window
| Tag | Filings |
|---|---|
| Procedural | |
| SAST | 4 |
| AGM / EGM | 2 |
| Annual Report | 1 |
| Book Closure | 1 |
| Compliance Certificate | 1 |
| Newspaper Publication | 1 |
| Record Date | 1 |
| Trading Window | 1 |
| Procedural sub-total | 12 |
| Total | 12 |
Disclosure regime
LODR Reg 30
Read with Schedule III Part A. An equity filer in BSE Group M, so the Regulation 30 disclosure framework and the Schedule III event list both apply.
Filing rhythm · 93 trading days
12 filings · 0 selected · busiest 2026-08-06
Filing rhythm · the twelve most recent
2026-07-202026-09-24
SelectedProcedural
Filings
12 in the window · 8 earlier on record
-
24 September 2026 ·
Closure of Trading Window
Intimation of Closure of Trading window
Insider Trading / SAST / Closure of Trading Window View filing →
-
2 September 2026 ·
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Amol Mujumdar
Insider Trading / SAST / Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 View filing →
-
2 September 2026 ·
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Amol Mujumdar
Insider Trading / SAST / Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 View filing →
-
1 September 2026 ·
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Amol Laxmikant Mujumdar
Insider Trading / SAST / Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 View filing →
-
31 August 2026 ·
Shareholder Meeting / Postal Ballot-Scrutinizer's Report
Scrutinizer Report
AGM/EGM / AGM View filing →
-
7 August 2026 ·
Newspaper Publication
Notice published by way of an advertisement in respect of 22nd Annual General Meeting (AGM) of the Company.
Company Update / Newspaper Publication View filing →
-
6 August 2026 ·
Intimation Of Record Date For Remote E-Voting
Intimation of Record Date for remote e-voting
Corp. Action / Record Date View filing →
-
6 August 2026 ·
Intimation Of Book Closure Shall Remain Closed From Sunday 23Rd August, 2026 To Saturday 29Th August, 2026 (Both Days Inc lusive) For Taking Record Of The Members Of The Company For The Purpose Of 22Nd (Twenty Second) Annual General Meeting Of The Company Scheduled To Be Held Saturday 29Th August, 2026 At 04:00 P.M
Intimation of Book Closure
Corp. Action / Book Closure View filing →
-
6 August 2026 ·
Reg. 34 (1) Annual Report.
Submission of Annual Report of Goldline Pharmaceutical Limited for FY 2025-26.
Others / Reg. 34 (1) Annual Report View filing →
-
6 August 2026 ·
Intimation Of Notice Of 22Nd Annual General Meeting Of Goldline Pharmaceutical Limited Will Be Held On Saturday, 29Th August, 2026 At 4:00 P.M. At Hotel Airport Centre Point, 131/1, Adjacent To Airport, Wardha Road, Somalwada, Nagpur, Maharashtra 440025
Intimation of notice of 22nd AGM of Goldline Pharmaceutical Limited.
AGM/EGM / AGM View filing →
-
30 July 2026 ·
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Prashant Shrikrishna Karkare
Insider Trading / SAST / Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 View filing →
-
20 July 2026 ·
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Certificate under Regulation 74(5)
Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 View filing →
RSS feed for Goldline Pharmaceutical Ltd · the 50 most recent filings